technetium-tc-99m-exametazime has been researched along with Graft-vs-Host-Disease* in 1 studies
1 other study(ies) available for technetium-tc-99m-exametazime and Graft-vs-Host-Disease
Article | Year |
---|---|
Bimodal granulocyte transit time through the human lung demonstrated by deconvolution analysis.
The lungs are an important site of granulocyte pooling. The aim of the study is to quantify pulmonary vascular granulocyte transit time using deconvolution analysis, as has previously been performed to measure pulmonary red cell transit time. Granulocyte and red cell studies were performed in separate groups of patients. Both cell types were labelled with Tc-99m, which for granulocyte labelling was complexed with hexamethylpropyleneamine oxime (HMPAO). The red cell impulse response function (IRF) was monoexponential with a median transit time of 4.3 s. The granulocyte IRF was biexponential in 19 of 22 subjects, 18 of whom had systemic inflammation (inflammatory bowel disease, systemic vasculitis or graft-vs-host disease) and four were controls without inflammatory disease. The median transit time of the fast component ranged from 20 to 25 s and of the slow component 120-138 s in the four patient groups. The fraction of cells undergoing slow transit correlated significantly with (a) mean granulocyte transit time and (b) the fraction showing shape change in vitro. We conclude that granulocyte transit time through the pulmonary circulation is bimodal and that shape-changed (activated) cells transit more slowly that non-activated cells. The size of the fraction undergoing slow transit is closely related to mean granulocyte transit time and is an important determinant of the size of the pulmonary vascular granulocyte pool. Topics: Cell Movement; Cell Size; Erythrocytes; Graft vs Host Disease; Granulocytes; Humans; Inflammatory Bowel Diseases; Pulmonary Circulation; Statistics, Nonparametric; Technetium Tc 99m Exametazime; Time Factors; Vasculitis | 1998 |